Cytokines and growth factors

How do growth factors cause cell differentiation?

How do growth factors cause cell differentiation?

As well as causing the proliferation of cells, growth factors can promote differentiation and even the death of cells. For example, the differentiation of neuronal progenitor cells to functional neuronal cells is regulated by so-called neurotrophic growth factors. As with the proliferative growth factors, neurotrophic growth factors initiate a complex cascade of events by binding to receptor proteins that span the cell surface:

Read More

How do growth factors cause cell division?

How do growth factors cause cell division?

Growth factors are crucial proteins in regulating various cellular processes, including differentiation and cell division. Simulation of cell division is triggered when particular growth factors bind cell receptors. This triggers a cascade of events through a series of steps that result in mitosis and cell division.

Read More

The more the better: not always for growth factors

The more the better: not always for growth factors

Most growth factors produce a sigmoidal dose response curve. However, biphasic responses can also be generated, even from a single receptor. The specific reasons underlying a biphasic dose response caused by FGF-2 biding to FGFR1 have been elucidated.

Read More

Catabolism vs anabolism: how growth factors govern key processes

Catabolism vs anabolism: how growth factors govern key processes

Metabolism in multicellular organisms is a complex interplay of biochemical processes that can be broadly categorized into two types: catabolism and anabolism. These processes, that are essential for maintaining life, enabling growth, and ensuring the proper functioning of cells and tissues, are controlled by growth factors and hormones.

Read More

Toxic effects of overdosing growth factors in cell culture

Toxic effects of overdosing growth factors in cell culture

Growth factors are critical to many aspects of cell culture including proliferation, differentiation and maintenance. Whilst the effects of insufficient growth factor, such as lack of proliferation, are readily apparent, the effects of adding too much growth factor can be less apparent but equally important.

Read More

Turning back the years by turning down IL11

Turning back the years by turning down IL11

Low-level chronic inflammation is a hallmark of ageing. A recent article in Nature suggests the goals of longevity research to increase healthspan, as well as lifespan, may be achieved by simply inhibiting an inflammatory cytokine.

Read More

Growth factor kinetics in vivo and in vitro

Growth factor kinetics in vivo and in vitro

It is important to understand that there is a big difference between in vivo and in vitro stability of growth factors. In-vivo, growth factor half-lives can be just a few minutes. But the same growth factors have in-vitro half-lives of a few hours. What causes this?

Read More

Pseudotime vs. actual time for genes

Pseudotime vs. actual time for genes

As well as actual, canonical time marked by ticking of a clock, time can be marked by events. Pseudotime and canonical expression time are concepts used in the study of gene expression dynamics, particularly in the context of developmental biology and single-cell RNA sequencing (scRNA-seq).

Read More

Overcoming barriers to cancer protein drug delivery

Overcoming barriers to cancer protein drug delivery

The delivery of protein drugs to metastatic tumors is fraught with obstacles that limit their efficacy. This article explores the barriers to the delivery of protein drugs to metastatic cancer and discusses strategies to overcome these challenges.

Read More

Harnessing Phagocytic Immune Cells to Breach Cancer Fortifications

Harnessing Phagocytic Immune Cells to Breach Cancer Fortifications

One of the most significant hurdles in combating metastatic cancer is the delivery of protein drugs to the affected sites. The cancer cells fortify themselves behind endothelial barriers and extracellular matrix, making it difficult for therapeutic agents to reach and destroy them. Employing phagocytic immune cells as Trojan horses to overcome these barriers has immense potential.

Read More